Treatment of Neurogenic Incontinence with Botulinum Toxin A
NEJM 342:665, Schurch,B.,et al, 2000
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
Migraine
NEJM 377:553-561, Charles, A., 2017
Botulinum Toxin Type A for Neuropathic Pain in Patients with Spinal Cord Injury
Ann Neurol 79:569-578, Han, Z.A.,et al, 2016
Cerebral Palsy
Lancet 383:1240-1248, Colver, A.,et al, 2014
The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014
Update on Blepharospasm: Report from the BEBRF International Workshop
Neurol 71:1275-1282, Hallett,M.,et al, 2008
Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003
Botulinum Toxin A and Chronic Low Back Pain
Neurol 56:1290-1293, Foster,L.,et al, 2001
Acute Caudate Vascular Lesions
Stroke 30:100-108, Kumral,E.,et al, 1999
Brachial Plexus Neuropathy After Botulinum Toxin Injection
Neurol 49:1176-1177, Tarsy,D., 1997
Pain and Remote Weakness in Limbs Injected with Botulinum Toxin A for Writer's Cramp
Lancet 346:154-156, Sheean,G.L.,et al, 1995
Cervical Dystonia:Clinical Findings and Associated Movement Disorders
Neurol 41:1088-1091, Jankovic,J.,et al, 1991
Thyroid-Associated Eye Disease:Clinical Management
Lancet 338:29-32, Fells,P., 1991
Brachial Plexopathy after Botulinum Toxin Injections
Neurol 40:1143, Glanzman,R.L.,et al, 1990
Treatment of Spasticity with Botulinum Toxin:A Double-Blind Study
Ann Neurol 28:512-515, Snow,B.J.,et al, 1990